Ewing CM, Ray AM, Lange EM, et al : Germline mutations in HOXB13 and prostate-cancer risk. N Engl J Med 366: 141-149, 2012
Consortium BCL :Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91: 1310-1316, 1999
Eeles R, Goh C, Castro E, et al : The genetic epidemiology of prostate cancer and its clinical implications. Nat Rev Urol 11: 18-31, 2014
Montgomery RB, Mostaghel EA, Vessella R, et al : Maintenance of intratumoral androgens in meta-static prostate cancer : a mechanism for castration-resistant tumor growth. Cancer Res 68: 4447-4454, 2008
Hamada A, Danesi R, Price DK, et al: Association of a CYP17 polymorphism with overall survival in Caucasian patients with androgen-independent prostate cancer. Urology 70: 217-220, 2007